ARCHIVES

Cancer Advocates Use Benefit Analysis To Press For Funds

This article is from The Cancer Letter archive.

Vol. 16 No. 19 | May 11, 1990

Download PDF Visit The Full Archive

Related Articles

Other DCT Concepts Approved By BSC

June 6, 1986

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

New Grants Awarded In Tobacco Research

February 17, 1978

New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy

December 31, 2004

Campus-Dweller Rabson Finds Comfort In NIH Security.

December 14, 2001